Recent works have revealed that PD patients exhibited increased LRRK2 protein expression and kinase activity in hyperactivated immune cells [37–40, 60, 61], which is consistent with our observations in both PD patients and A53T mice monocytes. This evidence concerns the gene LRRK2 and Parkinson disease.